{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:23:48Z","timestamp":1778826228172,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Grants-in-Aid for Scientific Research"},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Daiichi Sankyo Co., Ltd."},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Konica Minolta, Inc."},{"DOI":"10.13039\/501100003562","name":"Ministry of Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.prp.2020.152817","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T02:27:57Z","timestamp":1578623277000},"page":"152817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma"],"prefix":"10.1016","volume":"216","author":[{"given":"Masanori","family":"Matsuda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Wakejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Inamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingyon","family":"Mun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanobu","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2020.152817_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2020.152817_bib0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajim.10098","article-title":"Estimation of the incidence of pleural mesothelioma according to death certificates in France","volume":"42","author":"Iwatsubo","year":"2002","journal-title":"Am. J. Ind. Med."},{"key":"10.1016\/j.prp.2020.152817_bib0015","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/oem.2005.023200","article-title":"The french national mesothelioma surveillance program","volume":"63","author":"Goldberg","year":"2006","journal-title":"Occup. Environ. Med."},{"key":"10.1016\/j.prp.2020.152817_bib0020","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1097\/JTO.0b013e31822a3740","article-title":"Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy","volume":"6","author":"Kao","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2020.152817_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/PAI.0b013e31829b6fbd","article-title":"Value of calretinin immunostaining in diagnostic pathology: a review and update","volume":"22","author":"Ordonez","year":"2014","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2020.152817_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618808660","article-title":"Biomarkers in the diagnosis of pleural diseases: a 2018 update","volume":"12","author":"Porcel","year":"2018","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.prp.2020.152817_bib0035","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","article-title":"Immunohistochemical diagnosis of epithelioid mesothelioma: an update","volume":"129","author":"Ordonez","year":"2005","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2020.152817_bib0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41598-017-18545-x","article-title":"MUC4 immunohistochemistry is useful in distinguishing epithelioid mesothelioma from adenocarcinoma and squamous cell carcinoma of the lung","volume":"8","author":"Mawas","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2020.152817_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00000478-200302000-00002","article-title":"Expression of calretinin, thrombomodulin, keratin 5, and mesothelin in lung carcinomas of different types: an immunohistochemical analysis of 596 tumors in comparison with epithelioid mesotheliomas of the pleura","volume":"27","author":"Miettinen","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0050","doi-asserted-by":"crossref","first-page":"59314","DOI":"10.18632\/oncotarget.10653","article-title":"Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma","volume":"7","author":"Carbone","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2020.152817_bib0055","first-page":"559","article-title":"Expression of thrombomodulin, calretinin, cytokeratin 5\/6, D2-40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma","volume":"100","author":"Comin","year":"2014","journal-title":"Tumori"},{"key":"10.1016\/j.prp.2020.152817_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2016.08.003","article-title":"Spindle cell and pleomorphic (\"sarcomatoid\") carcinomas of the lung: an immunohistochemical analysis of 86 cases","volume":"59","author":"Weissferdt","year":"2017","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humpath.2013.09.005","article-title":"Immunohistochemical study of 36 cases of pulmonary sarcomatoid carcinoma--sensitivity of TTF-1 is superior to napsin","volume":"45","author":"Terra","year":"2014","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0070","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1365-2559.2009.03298.x","article-title":"Value of immunohistochemistry in the differential diagnosis of pleural sarcomatoid mesothelioma from lung sarcomatoid carcinoma","volume":"54","author":"Takeshima","year":"2009","journal-title":"Histopathol"},{"key":"10.1016\/j.prp.2020.152817_bib0075","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1046\/j.1365-2559.2003.01583.x","article-title":"Sarcomatoid mesothelioma and its histological mimics: a comparative immunohistochemical study","volume":"42","author":"Lucas","year":"2003","journal-title":"Histopathol"},{"key":"10.1016\/j.prp.2020.152817_bib0080","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification","volume":"10","author":"Travis","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.prp.2020.152817_bib0085","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3835(02)00383-X","article-title":"Loss of heterozygosity and the smoking index increase with decrease in differentiation of lung adenocarcinomas: etiologic implications","volume":"187","author":"Ishikawa","year":"2002","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2020.152817_bib0090","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2016"},{"key":"10.1016\/j.prp.2020.152817_bib0095","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.lungcan.2010.01.001","article-title":"Activation status of receptor tyrosine kinase downstream pathways in primary lung adenocarcinoma with reference of KRAS and EGFR mutations","volume":"70","author":"Hiramatsu","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.prp.2020.152817_bib0100","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/PAS.0000000000000458","article-title":"Pulmonary adenocarcinoma in situ: analyses of a large series with reference to smoking, driver mutations, and receptor tyrosine kinase pathway activation","volume":"39","author":"Sato","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0105","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.humpath.2013.07.021","article-title":"Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis","volume":"44","author":"Taliano","year":"2013","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0110","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2020.152817_bib0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/modpathol.2017.190","article-title":"Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"31","author":"Amatya","year":"2018","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2559.2009.03322.x","article-title":"Caveolin-1 is a novel immunohistochemical marker to differentiate epithelioid mesothelioma from lung adenocarcinoma","volume":"55","author":"Amatya","year":"2009","journal-title":"Histopathol"},{"key":"10.1016\/j.prp.2020.152817_bib0125","doi-asserted-by":"crossref","first-page":"397","DOI":"10.5858\/2008-132-397-AOITTD","article-title":"Application of immunohistochemistry to the diagnosis of malignant mesothelioma","volume":"132","author":"Marchevsky","year":"2008","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.prp.2020.152817_bib0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PAI.0b013e318187dd26","article-title":"Comparison of different clones (WT49 versus 6F-H2) of WT-1 antibodies for immunohistochemical diagnosis of malignant pleural mesothelioma","volume":"17","author":"Tsuta","year":"2009","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2020.152817_bib0135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.prp.2009.06.001","article-title":"Is D2-40 a useful marker for distinguishing malignant mesothelioma from pulmonary adenocarcinoma and benign mesothelial proliferations?","volume":"205","author":"eniz","year":"2009","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2020.152817_bib0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/PAS.0b013e31814faacf","article-title":"Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin","volume":"32","author":"Padgett","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2020.152817_bib0145","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/his.13073","article-title":"Utility and pitfalls of immunohistochemistry in the differential diagnosis between epithelioid mesothelioma and poorly differentiated lung squamous cell carcinoma","volume":"70","author":"Kushitani","year":"2017","journal-title":"Histopathol"},{"key":"10.1016\/j.prp.2020.152817_bib0150","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/modpathol.3800544","article-title":"The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study","volume":"19","author":"Ordonez","year":"2006","journal-title":"Mod. Pathol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819326299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819326299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:41:05Z","timestamp":1759732865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819326299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0344033819326299"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2020.152817","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2020.152817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152817"}}